FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059081338> ?p ?o ?g. }

• W2059081338 endingPage "344" @default.
• W2059081338 startingPage "335" @default.
• W2059081338 abstract "Abstract This laboratory is investigating the use of anti‐methotrexate IgG (AMI) and anti‐methotrexate Fab fragments (AMF) within an inverse targeting strategy that is designed to enhance the pharmacokinetic selectivity of intraperitoneal (i.p.) chemotherapy. The goal of this study was to develop enzyme‐linked immunosorbent assays (ELISAs) to determine concentrations of AMI and AMF in mouse and rat plasma. An antigen‐specific ELISA was developed for AMI and AMF in mouse and rat plasma. The assay was validated with respect to precision and accuracy by evaluating the recovery of AMI and AMF from mouse and rat plasma samples. Preliminary pharmacokinetic studies of AMI and AMF were performed in Sprague‐Dawley rats and Swiss Webster mice. The animals were instrumented with a jugular vein cannula and administered AMI or AMF, 15 mg kg−1 via the cannula. Plasma samples were taken at various time points and analyzed using the ELISA, and the observed concentration vs. time profiles were subjected to non‐compartmental pharmacokinetic analyses. Standard curves for the ELISAs were found to be linear over concentration ranges of 0–250 and 0–350 ng mL−1 for AMI and AMF, respectively. Intra‐assay and inter‐assay recovery of AMI and AMF from plasma samples were found to be within 15% of theoretical values. Preliminary pharmacokinetic investigations of AMI allowed estimation of AMI clearance to be 0.017 mL kg−1 min−1 in the rat and 0.043 mL kg−1 min−1 in the mouse. AMF clearance was estimated to be 0.038 and 1.93 mL kg−1 min−1 in the mouse and rat, respectively. In conclusion, ELISAs have been developed and validated for quantitation of AMI and AMF in rat and mouse plasma. The assays will allow further investigations of AMI and AMF pharmacokinetics." @default.
• W2059081338 created "2016-06-24" @default.
• W2059081338 creator A5006940157 @default.
• W2059081338 creator A5082379395 @default.
• W2059081338 date "2004-01-01" @default.
• W2059081338 modified "2023-09-23" @default.
• W2059081338 title "Development and Validation of Enzyme‐Linked Immunosorbent Assays for Quantification of Anti‐Methotrexate IgG and Fab in Mouse and Rat Plasma" @default.
• W2059081338 cites W1552338079 @default.
• W2059081338 cites W1974494143 @default.
• W2059081338 cites W1986926155 @default.
• W2059081338 cites W2000757443 @default.
• W2059081338 cites W2009636082 @default.
• W2059081338 cites W2010954378 @default.
• W2059081338 cites W2050276850 @default.
• W2059081338 cites W2070659784 @default.
• W2059081338 cites W2152911432 @default.
• W2059081338 cites W2255103618 @default.
• W2059081338 doi "https://doi.org/10.1081/ias-200033830" @default.
• W2059081338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15552588" @default.
• W2059081338 hasPublicationYear "2004" @default.
• W2059081338 type Work @default.
• W2059081338 sameAs 2059081338 @default.
• W2059081338 citedByCount "6" @default.
• W2059081338 countsByYear W20590813382017 @default.
• W2059081338 countsByYear W20590813382022 @default.
• W2059081338 crossrefType "journal-article" @default.
• W2059081338 hasAuthorship W2059081338A5006940157 @default.
• W2059081338 hasAuthorship W2059081338A5082379395 @default.
• W2059081338 hasConcept C112705442 @default.
• W2059081338 hasConcept C126322002 @default.
• W2059081338 hasConcept C141071460 @default.
• W2059081338 hasConcept C181199279 @default.
• W2059081338 hasConcept C185592680 @default.
• W2059081338 hasConcept C203014093 @default.
• W2059081338 hasConcept C2777956836 @default.
• W2059081338 hasConcept C2778074680 @default.
• W2059081338 hasConcept C2781059491 @default.
• W2059081338 hasConcept C3020079912 @default.
• W2059081338 hasConcept C43617362 @default.
• W2059081338 hasConcept C55493867 @default.
• W2059081338 hasConcept C71924100 @default.
• W2059081338 hasConcept C98274493 @default.
• W2059081338 hasConceptScore W2059081338C112705442 @default.
• W2059081338 hasConceptScore W2059081338C126322002 @default.
• W2059081338 hasConceptScore W2059081338C141071460 @default.
• W2059081338 hasConceptScore W2059081338C181199279 @default.
• W2059081338 hasConceptScore W2059081338C185592680 @default.
• W2059081338 hasConceptScore W2059081338C203014093 @default.
• W2059081338 hasConceptScore W2059081338C2777956836 @default.
• W2059081338 hasConceptScore W2059081338C2778074680 @default.
• W2059081338 hasConceptScore W2059081338C2781059491 @default.
• W2059081338 hasConceptScore W2059081338C3020079912 @default.
• W2059081338 hasConceptScore W2059081338C43617362 @default.
• W2059081338 hasConceptScore W2059081338C55493867 @default.
• W2059081338 hasConceptScore W2059081338C71924100 @default.
• W2059081338 hasConceptScore W2059081338C98274493 @default.
• W2059081338 hasIssue "4" @default.
• W2059081338 hasLocation W20590813381 @default.
• W2059081338 hasLocation W20590813382 @default.
• W2059081338 hasOpenAccess W2059081338 @default.
• W2059081338 hasPrimaryLocation W20590813381 @default.
• W2059081338 hasRelatedWork W1549843613 @default.
• W2059081338 hasRelatedWork W1964759623 @default.
• W2059081338 hasRelatedWork W2013875815 @default.
• W2059081338 hasRelatedWork W2030105938 @default.
• W2059081338 hasRelatedWork W2084825836 @default.
• W2059081338 hasRelatedWork W2372482429 @default.
• W2059081338 hasRelatedWork W2373237830 @default.
• W2059081338 hasRelatedWork W2387468073 @default.
• W2059081338 hasRelatedWork W2616641857 @default.
• W2059081338 hasRelatedWork W2996420923 @default.
• W2059081338 hasVolume "25" @default.
• W2059081338 isParatext "false" @default.
• W2059081338 isRetracted "false" @default.
• W2059081338 magId "2059081338" @default.
• W2059081338 workType "article" @default.